In comparison, for UCEC, the role is less clear, although the tumorigenic effect of FGFR2 in uterine cancer is evident at high levels of FBXW4 (6D), in line with previous studies reporting mutations that provide constitutive activation of FGFR2 in a subset of endometrial cancer69. The gene discussed is FBXW4; the disease is uterine cancer.